Literature DB >> 18443764

The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Jaromir Myslivecek1, Martin Klein, Martina Novakova, Jan Ricny.   

Abstract

Mammal heart tissue has long been assumed to be the exclusive domain of the M(2) subtype of muscarinic receptor, but data supporting the presence of other subtypes also exist. We have tested the hypothesis that muscarinic receptors other than the M(2) subtype are present in the heart as minor populations. We used several approaches: a set of competition binding experiments with pirenzepine, AFDX-116, 4-DAMP, PD 102807, p-F-HHSiD, AQ-RA 741, DAU 5884, methoctramine and tripinamide, blockage of M(1) muscarinic receptors using MT7 toxin, subtype-specific immunoprecipitation experiments and determination of phospholipase C activity. We also attempted to block M(1)-M(4) receptors using co-treatment with MT7 and AQ-RA 741. Our results show that only the M(2) subtype is present in the atria. In the ventricles, however, we were able to determine that 20% (on average) of the muscarinic receptors were subtypes other than M(2), with the majority of these belonging to the M(1) subtype. We were also able to detect a marginal fraction (6 +/- 2%) of receptors that, based on other findings, belong mainly to the M(5) muscarinic receptors. Co-treatment with MT7 and AQ-RA 741 was not a suitable tool for blocking of M(1)-M(4) receptors and can not therefore be used as a method for M(5) muscarinic receptor detection in substitution to crude venom. These results provide further evidence of the expression of the M(1) muscarinic receptor subtype in the rat heart and also show that the heart contains at least one other, albeit minor, muscarinic receptor population, which most likely belongs to the M(5) muscarinic receptors but not to that of the M(3) receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443764     DOI: 10.1007/s00210-008-0285-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  58 in total

1.  Expression of multiple subtypes of muscarinic receptors and cellular distribution in the human heart.

Authors:  H Wang; H Han; L Zhang; H Shi; G Schram; S Nattel; Z Wang
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

Review 2.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

3.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

Review 4.  International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

Authors:  M P Caulfield; N J Birdsall
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

5.  Differential cholinoceptor subtype-dependent activation of signal transduction pathways in neonatal versus adult rat atria.

Authors:  E S Borda; C Perez Leiros; J J Camusso; S Bacman; L Sterin-Borda
Journal:  Biochem Pharmacol       Date:  1997-04-04       Impact factor: 5.858

6.  Characterization of muscarinic receptors in guinea-pig uterus.

Authors:  H N Doods; K D Willim; H W Boddeke; M Entzeroth
Journal:  Eur J Pharmacol       Date:  1993-12-07       Impact factor: 4.432

7.  Aging of rat heart myocytes disrupts muscarinic receptor coupling that leads to inhibition of cAMP accumulation and alters the pathway of muscarinic-stimulated phosphoinositide hydrolysis.

Authors:  E Moscona-Amir; Y I Henis; M Sokolovsky
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

8.  Positive inotropic effect in the heart produced by acetylcholine.

Authors:  E Nadler; O Barnea; B Vidne; A Isakov; G Shavit
Journal:  J Basic Clin Physiol Pharmacol       Date:  1993 Jul-Sep

9.  M1 muscarinic receptors increase calcium current and phosphoinositide turnover in guinea-pig ventricular cardiocytes.

Authors:  M P Gallo; G Alloatti; C Eva; A Oberto; R C Levi
Journal:  J Physiol       Date:  1993-11       Impact factor: 5.182

10.  Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.

Authors:  M L Bolognesi; A Minarini; R Budriesi; S Cacciaguerra; A Chiarini; S Spampinato; V Tumiatti; C Melchiorre
Journal:  J Med Chem       Date:  1998-10-08       Impact factor: 7.446

View more
  9 in total

1.  Commercially available antibodies against human and murine histamine H₄-receptor lack specificity.

Authors:  Silke Beermann; Roland Seifert; Detlef Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-10       Impact factor: 3.000

2.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

3.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

4.  Severe Hypoglycemia-Induced Fatal Cardiac Arrhythmias Are Mediated by the Parasympathetic Nervous System in Rats.

Authors:  Candace M Reno; Justin Bayles; Yiqing Huang; Milan Oxspring; Annie M Hirahara; Derek J Dosdall; Simon J Fisher
Journal:  Diabetes       Date:  2019-08-22       Impact factor: 9.461

5.  M3 muscarinic receptors mediate positive inotropic responses in mouse atria: a study with muscarinic receptor knockout mice.

Authors:  Takio Kitazawa; Koichi Asakawa; Tatsuro Nakamura; Hiroki Teraoka; Toshihiro Unno; Sei-Ichi Komori; Masahisa Yamada; Jürgen Wess
Journal:  J Pharmacol Exp Ther       Date:  2009-05-08       Impact factor: 4.030

6.  Autoradiography of 3H-pirenzepine and 3H-AFDX-384 in Mouse Brain Regions: Possible Insights into M1, M2, and M4 Muscarinic Receptors Distribution.

Authors:  Paulina Valuskova; Vladimir Farar; Sandor Forczek; Iva Krizova; Jaromir Myslivecek
Journal:  Front Pharmacol       Date:  2018-02-20       Impact factor: 5.810

7.  Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4.

Authors:  Ruwan K Perera; Thomas H Fischer; Michael Wagner; Matthias Dewenter; Christiane Vettel; Nadja I Bork; Lars S Maier; Marco Conti; Juergen Wess; Ali El-Armouche; Gerd Hasenfuß; Viacheslav O Nikolaev
Journal:  Sci Rep       Date:  2017-11-09       Impact factor: 4.379

Review 8.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

Review 9.  Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.

Authors:  Ondrej Soukup; Michael Winder; Uday Kumar Killi; Vladimir Wsol; Daniel Jun; Kamil Kuca; Gunnar Tobin
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.